抗精神病药物:过去,现在和未来 (第二部分):第3条第2条
1Post-Acute Long-term Care physician and medical director.
The Senior care pharmacist
|January 24, 2024
概括
减少在护理机构中使用抗精神病药物仍然是一个挑战,尽管几十年的努力. 过去的改进计划产生了分散的结果,突出了在心理药物管理中需要更好的策略.
科学领域:
- 老年医学 老年医学
- 心理药理学 心理药理学
- 医疗保健政策 医疗保健政策
背景情况:
- 在护理机构中使用抗精神病药物是复杂的,反映了更广泛的医疗保健系统问题.
- 几十年来努力减少不必要的抗精神病药物使用,但取得的成功有限,心理药物仍然被广泛处方.
- 目前对这些环境中的行为,以人为中心的护理和药物使用的理解尚不完整.
研究的目的:
- 分析过去在护理机构管理抗精神病药物使用的各种观点和关键参与者.
- 评估这些举措的成果,并确定所吸取的经验教训.
- 为未来改善长期护理中药物管理的建议奠定基础.
主要方法:
- 审查影响护理机构药物使用的历史努力,特别是抗精神病药物.
- 分析碎片化,往往无效的改进举措.
- 检查针对心理药物使用的干预措施的结果.
主要成果:
- 过去的改进努力被描述为碎片化,无效和政治上具有挑战性.
- 尽管不分青红白地使用抗精神病药物显著减少,但精神药物在护理机构中仍然普遍存在.
- 管理痴呆症和其他行为问题的居民的整体改善尚不清楚.
结论:
- 在护理机构中使用抗精神病药物的历史揭示了药物管理的持续挑战.
- 过去的干预措施还没有完全解决不适当的精神药物处方的问题.
- 需要进一步的研究和精细的策略,以实现以人为中心的护理和药物实践的持久改进.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.1K
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
7.3K
相关概念视频
Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
Psychosis and Antipsychotic Drugs: Overview
259
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
259
Psychosis: Goals of Pharmacotherapy
131
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
131
Antipsychotic Drugs: Therapeutic Uses and Side Effects
214
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
214
Antipsychotic Drugs: Typical and Atypical Agents
201
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
201
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
648
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
648
